About the Study Study Type : Prospective, single-arm study evaluating the off-label use of GLP-1 RAs Duration : 24 months Participants : 110 adults with upper or lower extremity lymphedema (ISL Stages II and III) Primary Objective : Assess improvements in quality of life using the Lymphedema Life Impact Scale (LLIS) Secondary Objectives : Measure changes in limb volume, bioimpedance, BMI, compression use, and incidence of cellulitis Participants will receive GLP-1 RA treatment for six months, with the medication prescribed and managed by their primary healthcare provider
4 Efficiency and safety of dietary l-carnitine supplementation on health status are doubted recently
As the first telomerase-activating anti-aging drug, Epitalon signifies a shift from symptom-based treatments to mechanism-driven interventions, potentially extending human healthspan
Our clinic features thoughtfully designed treatment rooms, welcoming consultation areas, and a clean, relaxing atmosphere where you can feel confident and at ease from the moment you arrive
